Published in Brain on December 01, 2002
The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev (2010) 4.95
The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome. Proc Natl Acad Sci U S A (2003) 2.01
Achalasia: will genetic studies provide insights? Hum Genet (2010) 1.30
Triple-A syndrome with prominent ophthalmic features and a novel mutation in the AAAS gene: a case report. BMC Ophthalmol (2004) 1.18
Neurological features in adult Triple-A (Allgrove) syndrome. J Neurol (2011) 1.14
Genetic evaluation of ALADIN gene in early-onset achalasia and alacrima patients. J Neurogastroenterol Motil (2011) 0.96
Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis. Endocrinology (2013) 0.95
Long-term clinical follow-up and molecular genetic findings in eight patients with triple A syndrome. Eur J Pediatr (2012) 0.94
Case report of adult-onset Allgrove syndrome. Neurol Sci (2008) 0.89
Three siblings with triple A syndrome with a novel frameshift mutation in the AAAS gene and a review of 17 independent patients with the frequent p.Ser263Pro mutation. Eur J Pediatr (2008) 0.88
Premature Loss of Permanent Teeth in Allgrove (4A) Syndrome in Two Related Families. Iran J Pediatr (2010) 0.85
Triple A syndrome: 32 years experience of a single centre (1977-2008). Eur J Pediatr (2010) 0.83
Wernicke's encephalopathy in a patient with triple A (Allgrove) syndrome. J Neurol (2011) 0.80
Triple A (Allgrove) syndrome: an unusual association with syringomyelia. Ital J Pediatr (2013) 0.79
Clinical and molecular genetic findings in a 6-year-old Bosnian boy with triple A syndrome. Eur J Pediatr (2008) 0.78
Oxidative stress and adrenocortical insufficiency. J Endocrinol (2014) 0.77
Two siblings with triple A syndrome and novel mutation presenting as hereditary polyneuropathy. Eur J Pediatr (2010) 0.77
Longitudinal neuropsychological profile in a patient with triple a syndrome. Case Rep Pediatr (2013) 0.77
Inherited neuropathies: an update. J Neurol (2013) 0.76
Mutations of the AAAS gene in an Indian family with Allgrove's syndrome. World J Gastroenterol (2006) 0.75
Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy. Neural Plast (2017) 0.75
Identification of AAAS gene mutation in Allgrove syndrome: A report of three cases. Exp Ther Med (2015) 0.75
The small, spastic, and furrowed tongue of Allgrove syndrome. Neurology (2009) 0.75
The "Double A" phenotype: Portending Allgrove's syndrome and averting adrenal crisis. Indian J Endocrinol Metab (2012) 0.75
Achalasia in a patient with adult-onset Tay-Sachs disease. Dig Dis Sci (2006) 0.75
Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage (2002) 38.46
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet (2011) 9.10
Using Nonmedically Trained Interviewers to Collect Biomeasures in a National In-Home Survey. Field methods (2009) 8.24
Genetic properties of the maize nested association mapping population. Science (2009) 7.78
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol (2008) 6.76
A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet (2005) 5.81
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet (2011) 5.56
Statistical design and estimation for the national social life, health, and aging project. J Gerontol B Psychol Sci Soc Sci (2009) 5.01
Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci (2006) 4.87
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol (2007) 4.60
Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. Am J Hum Genet (2003) 4.58
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet (2010) 4.42
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain (2009) 4.01
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res (2011) 3.88
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell (2012) 3.39
Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med (2003) 3.37
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet (2010) 3.34
PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell (2009) 3.17
Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol (2011) 3.11
A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics (2012) 3.10
Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol (2007) 2.88
The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann Neurol (2003) 2.80
Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain (2007) 2.80
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation (2011) 2.62
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am J Hum Genet (2010) 2.61
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. AIDS (2007) 2.58
A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat Genet (2004) 2.44
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol (2011) 2.44
Parkin disease: a phenotypic study of a large case series. Brain (2003) 2.41
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proc Natl Acad Sci U S A (2005) 2.39
Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol (2008) 2.34
PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One (2008) 2.33
PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum Mol Genet (2010) 2.30
White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol (2005) 2.29
Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry (2012) 2.20
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Ann Neurol (2012) 2.20
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain (2003) 2.17
DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage (2010) 2.10
Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A. Am J Hum Genet (2007) 2.04
Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease. J Peripher Nerv Syst (2011) 2.03
Decreased heart rate variability predicts death in amyotrophic lateral sclerosis. Muscle Nerve (2012) 1.99
Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem (2010) 1.93
Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain (2013) 1.93
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress. J Neurochem (2006) 1.91
Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia. Ann Neurol (2013) 1.90
Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol (2013) 1.88
Blood oxygenation level dependent contrast resting state networks are relevant to functional activity in the neocortical sensorimotor system. Exp Brain Res (2005) 1.84
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci (2011) 1.82
Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet (2012) 1.78
Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J (2007) 1.77
Pupillographic findings in 39 consecutive cases of harlequin syndrome. J Neuroophthalmol (2008) 1.72
The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum Mol Genet (2004) 1.72
Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet (2003) 1.71
GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology. Genomics (2006) 1.70
Autosomal recessive, DYT2-like primary torsion dystonia: a new family. Neurology (2003) 1.69
PARK6-linked parkinsonism occurs in several European families. Ann Neurol (2002) 1.68
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. Hum Mol Genet (2012) 1.68
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. Brain (2010) 1.67
KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet (2011) 1.66
Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. Genome Res (2004) 1.65
A heterozygous effect for PINK1 mutations in Parkinson's disease? Ann Neurol (2006) 1.61
A genetically mediated bias in decision making driven by failure of amygdala control. J Neurosci (2009) 1.59
WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies. PLoS Biol (2010) 1.57
Corticobasal degeneration syndrome with basal ganglia calcification: Fahr's disease as a corticobasal look-alike? Mov Disord (2002) 1.57
An evaluation of four automatic methods of segmenting the subcortical structures in the brain. Neuroimage (2009) 1.53
Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. Am J Hum Genet (2013) 1.51
Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain (2010) 1.51
Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol (2002) 1.51
Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain (2012) 1.50
In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study. Exp Neurol (2010) 1.47
Patient knowledge of the risks of post-splenectomy sepsis. ANZ J Surg (2008) 1.46
The distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry (2011) 1.46
Parkinson's disease and cancer: two wars, one front. Nat Rev Cancer (2011) 1.45
PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology (2012) 1.44
Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet (2010) 1.42
Patient-specific insulin-resistance-guided infusion improves glycemic control in cardiac surgery. Ann Thorac Surg (2010) 1.41
Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat Cell Biol (2009) 1.41
Recent advances in the genetic neuropathies. Curr Opin Neurol (2016) 1.40
Cauda equina lymphoma: a case report including postmortem examination. Clin Adv Hematol Oncol (2011) 1.39
Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11. Nat Genet (2007) 1.38
Mitophagy and Parkinson's disease: the PINK1-parkin link. Biochim Biophys Acta (2010) 1.34
Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases. Neurology (2012) 1.33
A novel RAB7 mutation associated with ulcero-mutilating neuropathy. Ann Neurol (2004) 1.33
Clinical, pathological and genetic characterization of hereditary sensory and autonomic neuropathy type 1 (HSAN I). Brain (2005) 1.33
Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol (2002) 1.33
Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study. Brain (2002) 1.30
Mistargeting of SH3TC2 away from the recycling endosome causes Charcot-Marie-Tooth disease type 4C. Hum Mol Genet (2009) 1.29
Challenges for malaria elimination in Zanzibar: pyrethroid resistance in malaria vectors and poor performance of long-lasting insecticide nets. Parasit Vectors (2013) 1.28
Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability. Ann Neurol (2012) 1.25
Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease. Neuromolecular Med (2006) 1.24
Teamwork training improves the clinical care of trauma patients. J Surg Educ (2010) 1.24
Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genet (2010) 1.21
The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nat Neurosci (2013) 1.19